EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N‐terminal domain

Rob Geens, Jessica Stanisich, Olivier Beyens, Stijn D'Hondt, Jean-Michel Thiberge, Amber Ryckebosch, Anke De Groot, Stefan Magez, Didier Vertommen, Rogerio Amino, Hans De Winter, Alexander N Volkov and 2 more

Protein Science · 2024

DOI: 10.1002/pro.4852 ↗

At a glance

Journal article in Protein Science, 2024. Written by Rob Geens and 13 co-authors. Institution: Laboratory of Medical Biochemistry (LMB), University of Antwerp, Antwerp, Belgium. Major MEDLINE topics: Malaria Vaccines, Antimalarials, Malaria, Falciparum. Cited 11 times so far (Crossref); 93 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Agence Nationale de la Recherche, Fonds Wetenschappelijk Onderzoek, Universiteit Antwerpen.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The circumsporozoite protein (CSP) is the main surface antigen of the Plasmodium sporozoite (SPZ) and forms the basis of the currently only licensed anti‐malarial vaccine (RTS,S/AS01). CSP uniformly coats the SPZ and plays a pivotal role in its immunobiology, in both the insect and the vertebrate hosts. Although CSP's N‐terminal domain (CSP N ) has been reported to play an important role in multiple CSP functions, a thorough biophysical and structural characterization of CSP N is currently lacking. Here, we present an alternative method for the recombinant production and purification of CSP N from Plasmodium falciparum (PfCSP N ), which provides pure, high‐quality protein preparations with high yields. Through an interdisciplinary approach combining in‐solution experimental methods and in silico analyses, we provide strong evidence that PfCSP N is an intrinsically disordered region displaying some degree of compaction.

Subjects

MeSH terms (MEDLINE)

Malaria VaccinesAntimalarialsMalaria, FalciparumHumansPlasmodium falciparumProtozoan Proteins

Author keywords

Plasmodium falciparumbiophysicscircumsporozoite proteinintrinsic disorderrecombinant protein production and purificationstructural biology

Substances

Malaria VaccinesProtozoan ProteinsAntimalarials

Authors and institutions

  • Laboratory of Medical Biochemistry (LMB), University of Antwerp, Antwerp, Belgium.
  • Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium.
  • Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
  • Laboratory of Medicinal Chemistry (UAMC), University of Antwerp, Antwerp, Belgium.
  • Unit of Malaria Infection & Immunity, Institut Pasteur, Paris, France.
  • Ghent University Global Campus, Incheon, South Korea.

ORCID profiles: Peter Tompa, Yann G-J Sterckx

Funding

  • Agence Nationale de la Recherche
  • Fonds Wetenschappelijk Onderzoek
  • Universiteit Antwerpen

Cite

APA

Geens, R., Stanisich, J., Beyens, O., D'Hondt, S., Thiberge, J. M., Ryckebosch, A., De Groot, A., Magez, S., Vertommen, D., Amino, R., De Winter, H., Volkov, A. N., Tompa, P., & Sterckx, Y. G. (2024). Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N‐terminal domain. Protein Science. https://doi.org/10.1002/pro.4852

Vancouver

Geens R, Stanisich J, Beyens O, D'Hondt S, Thiberge JM, Ryckebosch A, et al. Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N‐terminal domain. Protein Science. 2024. doi:10.1002/pro.4852

BibTeX
@article{Geens2024,
  author = {Geens, Rob and Stanisich, Jessica and Beyens, Olivier and D'Hondt, Stijn and Thiberge, Jean-Michel and Ryckebosch, Amber and De Groot, Anke and Magez, Stefan and Vertommen, Didier and Amino, Rogerio and De Winter, Hans and Volkov, Alexander N and Tompa, Peter and Sterckx, Yann G-J},
  title = {Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N‐terminal domain},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.4852}
}
Start for free →